SAM
ABUS icon

Seelaus Asset Management’s Arbutus Biopharma ABUS Stock Holding History

Seelaus Asset Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,300
Closed -$51K – 167
2019
Q1 		$51K Hold
14,300
– – 0.05% 158
2018
Q4 		$55K Hold
14,300
– – 0.06% 137
2018
Q3 		$135K Hold
14,300
– – 0.11% 165
2018
Q2 		$104K Hold
14,300
– – 0.09% 164
2018
Q1 		$71K Buy
14,300
+1,500
+12% +$7.94K 0.06% 173
2017
Q4 		$65K Buy
+12,800
New +$75K 0.06% 175

Other funds holding ABUS

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return